Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000662:Amphetamines; D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors*; D001921:Brain / Q000378:metabolism; D002713:Chlorine; D002997:Clomipramine / Q000494:pharmacology*; D003984:Dibenzazepines / Q000494:pharmacology*; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D006892:Hydroxydopamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010647:Phenyl Ethers / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D012702:Serotonin Antagonists
D000662:Amphetamines; D001679:Biogenic Amines; D003984:Dibenzazepines; D006845:Hydrocarbons, Fluorinated; D006892:Hydroxydopamines; D010647:Phenyl Ethers; D011437:Propylamines; D012702:Serotonin Antagonists; D002713:Chlorine; D000661:Amphetamine; D002997:Clomipramine; D009638:Norepinephrine